Bank7 vs West Bancorporation
BSVN and WTBA side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BSVN and WTBA compare
Bank7 and West Bancorporation are about the same size, with market caps of $562M and $521M.
On earnings, West Bancorporation is cheaper: it trades at 13.0× trailing earnings, against 13.7× for Bank7.
West Bancorporation grew revenue faster over the last twelve months (15.8% versus 0.14% for Bank7).
Bank7 keeps more of each dollar of sales as profit, with a net margin of 42.8% compared with 37.9% at West Bancorporation.
Both pay dividends: Bank7 yields 1.9% and West Bancorporation 3.3%.
Bank7 scores higher on the StockData Score (14 against 12 for West Bancorporation), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BSVN | WTBA |
|---|---|---|
| Size and price | ||
| Market cap | $562M | $521M |
| Share price | $58.96 | $30.58 |
| Change, 1 year | 42.9% | 40.9% |
| Change, 5 years | 130% | −6.4% |
| Beta (5Y) | 0.66 | 0.70 |
| Employees | 125 | 175 |
| StockData Score | ||
| Total score | 14 (better) | 12 |
| Valuation score | 0 | 0 |
| Growth score | 2 | 2 |
| Performance score | 6 (better) | 5 |
| Health score | 3 (better) | 1 |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 13.7× | 13.0× (better) |
| P/S | 5.8× | 4.8× (better) |
| P/B | 2.1× | 1.9× (better) |
| P/FCF | 13.4× | 9.8× (better) |
| PEG | 1.16 | – |
| FCF yield | 7.5% | 10.2% (better) |
| Fair value | $44.24 | $25.33 |
| Margin of safety | −33.3% | −20.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 0.14% | 15.8% (better) |
| Revenue growth, 5Y average | 14.6% (better) | 0.60% |
| Net income growth (TTM) | −4.7% | 26.3% (better) |
| EPS growth (TTM) | −5.1% | 24.2% (better) |
| EPS growth, 5Y average | 17.0% (better) | −0.61% |
| Profitability | ||
| Net margin | 42.8% (better) | 37.9% |
| FCF margin | 43.5% | 49.7% (better) |
| Return on equity | 16.0% (better) | 15.5% |
| Financial health | ||
| Altman Z-score | 0.36 (better) | 0.23 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.9% | 3.3% (better) |
| Payout ratio | 24.8% | 42.2% |
| Years of dividend growth | 5 (better) | 0 |
| Dividend growth, 5Y average | 20.0% (better) | 3.5% |
| Buyback yield | 0.28% | – |
| Shareholder yield | 2.2% | 3.3% (better) |
| Ownership | ||
| Held by institutions | 33.6% | 50.2% |
| Held by insiders | 8.1% | 6.1% |
| Insider net buying, 12 months | −$1.3M | −$193K (better) |
| Short interest, % of float | 1.8% | 2.3% |
Go deeper
- BSVN stock overview
- BSVN income statement
- BSVN valuation and score
- WTBA stock overview
- WTBA income statement
- WTBA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.